Drinabant
id:
drinabant-187-18764680
title:
Drinabant
text:
Drinabant (INN; AVE-1625) is a drug that acts as a selective CB1 receptor antagonist, which was under investigation varyingly by Sanofi-Aventis as a treatment for obesity, schizophrenia, Alzheimer's disease, Parkinson's disease, and nicotine dependence. Though initially studied as a potential treatment for a variety of different medical conditions, Sanofi-Aventis eventually narrowed down the therapeutic indications of the compound to just appetite suppression. Drinabant reached phase IIb clinica
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Drinabant
date created:
2012-05-13T07:58:56Z
date modified:
2024-09-08T16:54:07Z
main entity:
{"identifier":"Q5307675","url":"https://www.wikidata.org/entity/Q5307675"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/1d/Drinabant.svg","width":512,"height":392}
fields total:
13
integrity:
16